Our surveys to understand the impact of the COVID-19 pandemic on the PH community have now closed, with over 1000 responses received.
2 August 2021
The PHA UK has launched new research to understand the impact of the COVID-19 pandemic on people affected by pulmonary hypertension.
7 June 2021
A survey amongst the UK pulmonary hypertension community has shown overwhelming support for the development of a soft robotic heart that aims to reduce deaths from heart failure.
3 June 2021
The PHA UK has launched a new survey to help researchers who are looking at the use of cutting-edge remote monitoring technology to help patients get the best results from their medication.
18 March 2021
PRESS RELEASE: People living with the rare lung disease pulmonary hypertension saw their physical health deteriorate whilst shielding, according to a new report.
1 November 2020A message on behalf of the UK’s specialist centres PH patients have been shielded during the COVID19 pandemic. Consequently in March, the UK centres all agreed to suspend blood testing for everyone prescribed an Endothelin receptor antagonist (Ambrisentan, Bosentan or Macitentan) . The current government advice is for shielding to end on August 1st. […]
3 July 2020